Zhao Yan, Andoh Tina, Charles Fatima, Reddy Priyanka, Paul Kristina, Goar Harsh, Durdana Ishrat, Golder Caiden, Hardy Ashley, Juntilla Marisa M, Yang Soo-Ryum, Lin Chien-Yu, Sagiv-Barfi Idit, Geller Benjamin S, Moore Stephen, Thakkar Dipti, Boyd-Kirkup Jerome D, Peng Yan, Ford James M, Telli Melinda L, Zhang Song, Kurian Allison W, West Robert B, Yue Tao, Lipchik Andrew M, Snyder Michael P, Gruber Joshua J
Departments of Medicine and Molecular Biology, Cecil H. and Ida Green Center for Reproductive Sciences, UT Southwestern Medical Center, Dallas, TX, 75235.
Departments of Genetics, Stanford University, Palo Alto, CA, 94305.
bioRxiv. 2025 Jan 5:2025.01.05.631401. doi: 10.1101/2025.01.05.631401.
VISTA is a key immune checkpoint receptor under investigation for cancer immunotherapy; however, its signaling mechanisms remain unclear. Here we identify a conserved four amino acid (NPGF) intracellular motif in VISTA that suppresses cell proliferation by constraining cell-intrinsic growth receptor signaling. The NPGF motif binds to the adapter protein NUMB and recruits Rab11 endosomal recycling machinery. We identify and characterize a class of triple-negative breast cancers with high VISTA expression and low proliferative index. In tumor cells with high VISTA levels, the NPGF motif sequesters NUMB at endosomes, which interferes with epidermal growth factor receptor (EGFR) trafficking and signaling to suppress tumor growth. These effects do not require canonical VISTA ligands, nor a functioning immune system. As a consequence of VISTA expression, EGFR receptor remains abnormally phosphorylated and cannot propagate ligand-induced signaling. Mutation of the VISTA NPGF domain reverts VISTA-induced growth suppression in multiple breast cancer mouse models. These results define a mechanism by which VISTA represses NUMB to control malignant epithelial cell growth and signaling. They also define distinct intracellular residues that are critical for VISTA-induced cell-intrinsic signaling that could be exploited to improve immunotherapy.
VISTA是一种正在接受癌症免疫治疗研究的关键免疫检查点受体;然而,其信号传导机制仍不清楚。在此,我们在VISTA中鉴定出一个保守的四氨基酸(NPGF)细胞内基序,该基序通过限制细胞内在生长受体信号传导来抑制细胞增殖。NPGF基序与衔接蛋白NUMB结合,并募集Rab11内体循环机制。我们鉴定并表征了一类VISTA高表达且增殖指数低的三阴性乳腺癌。在VISTA水平高的肿瘤细胞中,NPGF基序将NUMB隔离在内体中,这会干扰表皮生长因子受体(EGFR)的运输和信号传导,从而抑制肿瘤生长。这些效应不需要典型的VISTA配体,也不需要正常运作的免疫系统。由于VISTA的表达,EGFR受体仍异常磷酸化,无法传播配体诱导的信号。在多个乳腺癌小鼠模型中,VISTA NPGF结构域的突变可逆转VISTA诱导的生长抑制。这些结果确定了一种机制,即VISTA通过抑制NUMB来控制恶性上皮细胞的生长和信号传导。它们还确定了对于VISTA诱导的细胞内在信号传导至关重要的不同细胞内残基,可利用这些残基来改善免疫治疗。